Thursday, September 03, 2015 2:16:32 PM
http://www.equities.com/media-gallery/170-nanoviricides-inc?category_id=65
It's not very long and the first two minutes should be enough to give pause to those who are relying on Dr. (being called anything other than "Doctor" pisses him off big time) Seymour's representations to make their investment decisions. You quoted something notable from those initial statements in your post:
"...in two weeks they can create a new drug. For example, the SARS virus...give me two weeks and I can have it..."
The interview didn't get much attention on this board at the time for some reason, but we couldn't know at the time how some of his assurances would play out. Now we do.
I wonder how many of the people that saw it at the time believed NNVC would be $8 by the end of that year and double digits for 2014 based on what Dr. S had to say, as you apparently did.
ps. At some point he's asked about his background and he provides a pretty thorough response...neglecting to mention his stint with SALIVA DIAGNOSTIC SYSTEMS, INC. for some reason.
Did he forget to mention someone in his discussion of NNVC management? If there was one name that should have been mentioned, whose name would that be?
pps. I found Dr. Seymour's lighthearted comments about some debilitating and deadly diseases more than a little distasteful. He appears to have a screw loose at times.
A belated "thank you" for the link.
“I have had a wonderful time but this wasn't it.”
..........Groucho
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM